Novonix Valuation
| NVX Stock | USD 1.56 0.08 5.41% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Novonix Ltd ADR secures a last-minute Real Value of $1.96 per share. The latest price of the firm is $1.56. Our model forecasts the value of Novonix Ltd ADR from analyzing the firm fundamentals such as Return On Equity of -0.47, shares outstanding of 159.26 M, and Operating Margin of (7.86) % as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Novonix's price fluctuation is dangerous at this time. Calculation of the real value of Novonix Ltd ADR is based on 3 months time horizon. Increasing Novonix's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Novonix is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Novonix Stock. However, Novonix's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.56 | Real 1.96 | Hype 1.62 | Naive 1.64 |
The intrinsic value of Novonix's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Novonix's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Novonix Ltd ADR helps investors to forecast how Novonix stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Novonix more accurately as focusing exclusively on Novonix's fundamentals will not take into account other important factors: Novonix Total Value Analysis
Novonix Ltd ADR is now anticipated to have company total value of 254.47 M with market capitalization of 248.45 M, debt of 70.42 M, and cash on hands of 207.08 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Novonix fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
254.47 M | 248.45 M | 70.42 M | 207.08 M |
Novonix Investor Information
The company has price-to-book ratio of 1.81. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Novonix Ltd ADR recorded a loss per share of 0.83. The entity last dividend was issued on the March 11, 2015. Based on the key measurements obtained from Novonix's financial statements, Novonix Ltd ADR is not in a good financial situation at this time. It has a very high probability of going through financial hardship in August.Novonix Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Novonix has an asset utilization ratio of 2.59 percent. This suggests that the Company is making $0.0259 for each dollar of assets. An increasing asset utilization means that Novonix Ltd ADR is more efficient with each dollar of assets it utilizes for everyday operations.Novonix Ownership Allocation
Novonix Ltd ADR maintains a total of 159.26 Million outstanding shares. Roughly 99.58 % of Novonix outstanding shares are held by general public with 0.42 % by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Novonix Profitability Analysis
The company reported the last year's revenue of 5.85 M. Reported Net Loss for the year was (74.82 M) with profit before taxes, overhead, and interest of 4.08 M.About Novonix Valuation
Our relative valuation model uses a comparative analysis of Novonix. We calculate exposure to Novonix's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Novonix's related companies.Novonix Limited develops and supplies battery materials, equipment, and services to the lithium-ion battery market in North America. Novonix Limited was incorporated in 2012 and is based in Brisbane, Australia. Novonix is traded on NASDAQ Exchange in the United States.
Novonix Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 124.2 M |
Additional Tools for Novonix Stock Analysis
When running Novonix's price analysis, check to measure Novonix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novonix is operating at the current time. Most of Novonix's value examination focuses on studying past and present price action to predict the probability of Novonix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novonix's price. Additionally, you may evaluate how the addition of Novonix to your portfolios can decrease your overall portfolio volatility.